ACTA1 and Hepatic fibrosis: The results showed that compared with the MCD model group, the distribution of α-SMA in the liver tissues was reduced after the administration of GER (Figures 6F–G), demonstrating that GER was able to inhibit the expression of α-SMA and block HSC activation in mice with liver fibrosis.